Jack · Alzheimer's & dementia : the journal of the Alzheimer's Association 2018 · expert consensus framework · n=?

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Cited 10715 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Expert consensus research framework and narrative review containing no new empirical data

PubMed 29653606 · doi:10.1016/j.jalz.2018.02.018 · record verified 2026-08-26

What was done

The National Institute on Aging and Alzheimer's Association (NIA-AA) developed an updated, unified research framework to redefine Alzheimer's disease (AD) biologically using in vivo biomarkers or postmortem pathology rather than clinical syndromal presentation. The framework establishes an AT(N) classification system grouping biomarkers of beta-amyloid deposition [A], pathologic tau [T], and neurodegeneration [N], alongside continuous or categorical cognitive staging schemes (a three-stage syndromal and a six-stage numeric scheme).

What was found

No quantitative experimental data or statistical outcomes are reported in the abstract. The paper establishes a conceptual classification system separating the biological definition of AD from its clinical symptoms, intended to provide a standardized research taxonomy for observational studies and clinical trials.

Why it matters

Shifting the research definition of Alzheimer's disease from clinical syndromes to biological biomarkers enables more precise participant selection in interventional trials and clarifies the temporal sequence of pathological events leading to cognitive impairment.

Limits

The framework is explicitly intended for research and is premature and inappropriate for general clinical practice. The abstract reports no empirical validation data, sample size, or diagnostic accuracy metrics, and notes that the framework requires validation in diverse populations and that amyloid and tau alterations may not necessarily be causal drivers of pathogenesis.

Cited by